Your email has been successfully added to our mailing list.

×
0 0 0 0 0 0.0451977401129944 0.00282485875706221 0.0203389830508475
Stock impact report

Neoleukin Therapeutics and Aquinox Pharmaceuticals Complete Merger Transaction

AQUINOX PHARMACEUTICALS (AQXP) 
Last aquinox pharmaceuticals earnings: 11/8 09:05 am Check Earnings Report
US:NASDAQ Investor Relations: investor.aqxpharma.com/investor-relations
Company Research Source: GlobeNewswire
Nasdaq Ticker Symbol “NLTX” to be effective Monday, August 12, 2019 SEATTLE, Aug. 09, 2019 (GLOBE NEWSWIRE) -- Neoleukin Therapeutics, Inc. (“Neoleukin”), a biopharmaceutical company utilizing sophisticated computational methods to design de novo protein therapeutics, today announced the completion of the previously disclosed merger transaction with Aquinox Pharmaceuticals, Inc. (NASDAQ:AQXP). Aquinox Pharmaceuticals, Inc. will be renamed Neoleukin Therapeutics, Inc. and will trade under the new ticker symbol “NLTX” beginning on Monday, August 12, 2019, on the Nasdaq Global Market. Neoleukin is a biopharmaceutical company creating next generation immunotherapies using de novo protein design technology. Following the close of the transaction, and after giving effect to con Show less Read more
Impact Snapshot
Event Time:
AQXP
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for AQXP alerts
Opt-in for
AQXP alerts

from News Quantified
Opt-in for
AQXP alerts

from News Quantified